The Only Complete Online Marketing Firm
Wednesday, April 22, 2015
Increasing Tysabri Dosing Interval May Cut PML Risk
(MedPage Today) -- No sacrifice of efficacy seen in retrospective analysis.
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment